Sign Up
Stories
Assertio Holdings Faces Securities Law Investigation
Share
Biotech Drug Trials Face Setbacks
Class Action Lawsuits Filed Against Apel...
Legal Actions & Inducements Update
AlloVir Class Action Lawsuit Filed
AlloVir Faces Class Action Allegations
AlloVir Faces Class Action Lawsuit
Overview
API
Multiple law firms are investigating Assertio Holdings, Inc. (ASRT) for potential violations of federal securities laws related to its reliance on Indocin products and the FDA's approval of a generic version of Indocin Suppositories. The investigation stems from significant drops in the company's stock price, failure to meet consensus estimates for financial results, and the departure of its CEO. The law firms are encouraging investors to seek legal advice and consider joining the lawsuits.
Ask a question
How do investigations like these influence investor confidence and the overall market perception of the involved companies?
How might the outcome of these investigations impact the reputation and financial stability of Assertio Holdings, Inc. (ASRT) and BioVie Inc. (BIVI)?
What measures can companies take to ensure compliance with federal securities laws and maintain investor trust?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Jan 2024
Coverage